Literature DB >> 11127967

Glucosamine and chondroitin sulfates in the treatment of osteoarthritis: a survey.

G C de los Reyes1, R T Koda, E J Lien.   

Abstract

For more than 30 years, non-steroidal anti-inflammatory drugs (NSAIDs) have been used as standards in the treatment of osteoarthritis (OA). Serious and often life-threatening adverse effects due to these agents are common. Clinical findings have revealed that glucosamine sulfate and chondroitin sulfate are effective and safer alternatives to alleviate symptoms of OA. Experimental evidence indicates that these compounds and their low molecular weight derivatives have a particular tropism for cartilage where they serve as substrates in the biosynthesis of component building blocks. This paper is a literature review of the chemistry, mechanism of action, pharmacokinetics, clinical efficacy and safety of these two nutraceuticals.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11127967     DOI: 10.1007/978-3-0348-8385-6_3

Source DB:  PubMed          Journal:  Prog Drug Res        ISSN: 0071-786X


  8 in total

Review 1.  Immunological activity of chondroitin sulfate.

Authors:  Toshihiko Toida; Shinobu Sakai; Hiroshi Akiyama; Robert J Linhardt
Journal:  Adv Pharmacol       Date:  2006

2.  A suggested guiding panel of seromarkers for efficient discrimination between primary and secondary human hepatocarcinoma.

Authors:  Nabil Mohie Abdel-Hamid; M M Abouzied; M H Nazmy; M A Fawzy; A S Gerges
Journal:  Tumour Biol       Date:  2015-09-19

Review 3.  Chondroitin sulphate: a focus on osteoarthritis.

Authors:  Mamta Bishnoi; Ankit Jain; Pooja Hurkat; Sanjay K Jain
Journal:  Glycoconj J       Date:  2016-05-19       Impact factor: 2.916

4.  Premalignant variations in extracellular matrix composition in chemically induced hepatocellular carcinoma in rats.

Authors:  Nabil M Abdel-Hamid
Journal:  J Membr Biol       Date:  2009-08-18       Impact factor: 1.843

5.  Selection of reliable reference genes for qPCR studies on chondroprotective action.

Authors:  Stefan Toegel; Wenwen Huang; Claudia Piana; Frank M Unger; Michael Wirth; Mary B Goldring; Franz Gabor; Helmut Viernstein
Journal:  BMC Mol Biol       Date:  2007-02-26       Impact factor: 2.946

Review 6.  Heparan sulfate proteoglycans and their modification as promising anticancer targets in hepatocellular carcinoma.

Authors:  Mohammed A Alshehri; Moath M Alshehri; Naif N Albalawi; Moshari A Al-Ghamdi; Mohammed M H Al-Gayyar
Journal:  Oncol Lett       Date:  2021-01-04       Impact factor: 2.967

7.  Flaxseed extract reduces tissue accumulation and enhances urinary excretion of chondroitin sulphate in the rat: a possible new path in substrate reduction therapy for mucopolysaccharidosis.

Authors:  Sabir Es-Said; Karima Lafhal; Abdelaati Elkhiat; Miloud Hammoud; Noureddine Regbaoui; Aicha Ezoubeiri; Rachida Makbal; Safia Sbyea; Omar Elhiba; Souad Sellami; Hanane Rais; Abdallah Karim; Halima Gamrani; Noureddine Rada; Mohammed Bouskraoui; Naima Fdil
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

8.  Glucosamine and chondroitin sulfate supplementation to treat symptomatic disc degeneration: biochemical rationale and case report.

Authors:  Wim J van Blitterswijk; Jos C M van de Nes; Paul I J M Wuisman
Journal:  BMC Complement Altern Med       Date:  2003-06-10       Impact factor: 3.659

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.